Supplementary table II. Pemphigus vulgaris and pemphigus foliaceus. Adverse events in 24 pemphigus patients treated with rituximab

Adverse events are grouped into infusion-related and serious adverse events. Values represent number of patients (% of total cohort, N=24). Events not observed are listed for completeness.